Kronisk inflammatorisk demyeliniserende polyneuropati

Lars Kjøbsted Markvardsen*, Thomas Harbo, Jakob Vormstrup Holbech, Hatice Tankisi, Ingelise Christiansen, Niels Kjær Olsen, Johannes Jakobsen, Søren Hein Sindrup, Henning Andersen

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Abstract

In this review, we discuss chronic inflammatory demyelinating polyneuropathy (CIDP), which is a disease with proximal and distal weakness and sensory disturbances resulting in impaired daily activity. The diagnosis is based on the clinical presentation and electrophysiology demonstrating demyelination in the peripheral nerves. CIDP can be successfully treated with immunoglobulin, glucocorticoids or plasma exchange, and during the latest decade, immunoglobulin has been administered subcutaneously improving patients’ flexibility and autonomy. By time, 30% of the patients will remit, and maintenance treatment will no longer be necessary.

Bidragets oversatte titelChronic inflammatory demyelinating polyneuropathy
OriginalsprogNorsk
TidsskriftUgeskrift for Laeger
Vol/bind181
Nummer9
Sider (fra-til)2-6
Antal sider5
ISSN0041-5782
StatusUdgivet - 27 apr. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Kronisk inflammatorisk demyeliniserende polyneuropati'. Sammen danner de et unikt fingeraftryk.

Citationsformater